Speech-Language Pathologists in Damascus, MD Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Ellen Marshall Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24555 Cutsail Dr, Damascus, MD 20872 Phone: 240-740-5180

Anna Connolly, M. A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9930 Moyer Rd, Damascus, MD 20872 Phone: 240-740-2580

Mindy Postal Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25400 Oak Dr, Damascus, MD 20872 Phone: 240-207-2440

Bridget Stokes Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24700 Kings Valley Rd, Damascus, MD 20872 Phone: 301-916-5407

Mrs. Lori Record, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25921 Ridge Rd, Damascus, MD 20872 Phone: 240-207-2400

Samantha Hyunkyung Kim, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24555 Cutsail Dr, Damascus, MD 20872 Phone: 240-740-5180

Mrs. Nancy Thorner, M.A., CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24322 Red Blaze Dr, Damascus, MD 20872 Phone: 301-368-9193    Fax: 301-368-9194

News Archive

Obesity a major health issue in Canada

With 59% of Canadian adults being overweight and 23% being obese, plus the disturbing increase in childhood obesity, it is clear that obesity is a major individual and public health issue in Canada.

Promising new evidence for the optimal use of biologic therapies for rheumatoid arthritis

A major cause of pain and disability, rheumatoid arthritis (RA) is also potentially the most treatable form of chronic arthritis. Researchers, doctors, and patients agree that a group of drugs called disease-modifying antirheumatic drugs (DMARDs) can effectively reduce joint pain and stiffness.

Rubicon Genomics' PicoPlex linear WGA technology proves effective in clinical study

Rubicon Genomics today announced that its PicoPlex linear whole genome amplification technology was proven to be effective in an independent clinical study organized by the European Society for Human Reproduction and Embryology. At a press conference during its 26th Annual Meeting in Rome, ESHRE reported the success of its "groundbreaking proof of principle study" showing that a new approach incorporating PicoPlex could more accurately detect and characterize chromosomal abnormalities in human eggs.

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department's Armed Forces Institute of Regenerative Medicine will fund the Phase IIb clinical trial of the company's flagship StrataGraft living human skin substitute tissue.

Read more Medical News

› Verified 2 days ago